Showing results (61-70 of 116) with videos related to
Sort By:
Pageof 12
Diabetes Care|June 6, 2014
Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuriaJan Skupien, James H Warram, Monika A Niewczas, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 3, 2004
Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta miceQiuling Fan, Jie Liao, Michimasa Kobayashi, et al.Diabetes Research and Clinical Practice|June 14, 2008
Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal functionTomohito Gohda, Mitsuo Tanimoto, Ju-Young Moon, et al.Nephrology (Carlton, Vic.)|September 22, 2005
Genetic susceptibility to type 2 diabetic nephropathy in human and animal modelsTomohito Gohda, Mitsuo Tanimoto, Kaori Watanabe-Yamada, et al.Scientific Reports|December 15, 2020
Poor oral hygiene and dental caries predict high mortality rate in hemodialysis: a 3-year cohort studyKoji Mizutani, Risako Mikami, Tomohito Gohda, et al.Journal of Nephrology|July 5, 2011
Identification of quantitative trait loci for diabetic nephropathy in KK-Ay/Ta miceTatsuya Aoki, Shigeru Kaneko, Mitsuo Tanimoto, et al.Metabolism: Clinical and Experimental|July 16, 2004
Altered mouse cholinephosphotransferase gene expression in kidneys of type 2 diabetic KK/TA mouseTomohito Gohda, Mitsuo Tanimoto, Kenji Shiina, et al.Metabolism: Clinical and Experimental|January 17, 2007
Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta miceMitsuo Tanimoto, Tomohito Gohda, Shigeru Kaneko, et al.Endocrinology, Diabetes & Metabolism|July 1, 2025
Association of the Glycated Albumin-to-Glycated Haemoglobin Ratio With Mortality in Type 2 Diabetes: A Retrospective Cohort AnalysisTomohito Gohda, Nozomu Kamei, Marenao Tanaka, et al.Scientific Reports|October 19, 2018
Association between circulating tumor necrosis factor-related biomarkers and estimated glomerular filtration rate in type 2 diabetesNozomu Kamei, Mami Yamashita, Yuji Nishizaki, et al.Pageof 12